Virtual biopsy for prostate cancer using PSMA PET and AI
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a special PET scan (PSMA PET) and artificial intelligence to see if we can detect prostate cancer without a needle biopsy. It is for men who are either already scheduled for a PET scan or who have symptoms or high PSA suggesting prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been referred for a PSMA PET scan (either before or without a prior biopsy)
- You have not had your prostate surgically removed
- You weigh less than 100 kg (about 220 lbs)
- You do not have any metal implants or other things that make an MRI unsafe
- You have symptoms or elevated PSA levels that suggest prostate cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
This study tests whether a special type of PET/MRI scan (PSMA PET/MRI) can help doctors find hidden prostate cancer in men who have a rising PSA but previous negative biopsies and a non-suspicious MRI. It aims to improve detection without skipping needed treatment.
This trial tests a new, all-in-one PET/MRI scan to see if it can better find aggressive prostate cancer in men who need a biopsy. It may help avoid unnecessary biopsies and give a clearer picture of your condition.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.